Researchers Shed Light on Signaling Pathway Responsible for Head and Neck Cancers
A new study from researchers at Boston University Chobanian & Avedisian School of Medicine shows how computational approaches can drive important biomedical discoveries. The study aimed to better characterize oral tumor heterogeneity, including aggressive cell subpopulations, and identify candidate vulnerabilities that could be targeted therapeutically. The findings are of timely significance, providing new information about additional therapeutic targets for head and neck cancer. The findings appear online in the journal Translational Research.
To read the press release, click here.